Endostatin inhibits human tongue carcinoma cell invasion and intravasation and blocks the activation of matrix metalloprotease-2, -9, and -13.
about
Type XVIII collagen degradation products in acute lung injuryGelatinase B/MMP-9 in Tumour Pathogenesis and ProgressionGenetically engineered endostatin-lidamycin fusion proteins effectively inhibit tumor growth and metastasis.Chemical inhibition of prometastatic lysyl-tRNA synthetase-laminin receptor interaction.Dihydromyricetin inhibits migration and invasion of hepatoma cells through regulation of MMP-9 expression.Tunicate cytostatic factor TC14-3 induces a polycomb group gene and histone modification through Ca(2+) binding and protein dimerization.Serum endostatin levels are elevated in colorectal cancer and correlate with invasion and systemic inflammatory markers.(Pro)renin receptor triggers distinct angiotensin II-independent extracellular matrix remodeling and deterioration of cardiac function.Type I collagen gene suppresses tumor growth and invasion of malignant human glioma cellsEffects of endostatin on expression of vascular endothelial growth factor and its receptors and neovascularization in colonic carcinoma implanted in nude mice.Endostatin's emerging roles in angiogenesis, lymphangiogenesis, disease, and clinical applications.Endostatin and endorepellin: A common route of action for similar angiostatic cancer avengersNeo-angiogenesis and the premalignant micro-circulatory augmentation of early colon carcinogenesis.Ten years in the life of an enzyme: the story of the human MMP-13 (collagenase-3).Is collagenase-3 (MMP-13) expression in chondrosarcoma of the jaws a true marker for tumor aggressiveness?Endostatin and angiostatin are increased in diabetic patients with coronary artery disease and associated with impaired coronary collateral formationAn evolutionary explanation for the perturbation of the dynamics of metastatic tumors induced by surgery and acute inflammation.A novel organotypic model mimics the tumor microenvironment.FOXO3a promotes tumor cell invasion through the induction of matrix metalloproteinases.Combination of antiangiogenesis with chemotherapy for more effective cancer treatment.Prognostic value of type XXII and XXIV collagen mRNA expression in head and neck cancer patients.Proteoglycans: master modulators of paracrine fibroblast-carcinoma cell interactions.Matricryptins and matrikines: biologically active fragments of the extracellular matrix.Endostatin Sensitizes p53-Deficient Non-Small Cell Lung Cancer to Genotoxic Chemotherapy by Targeting DNA-PKcs.Reduced nonprotein thiols inhibit activation and function of MMP-9: implications for chemoprevention.Collagens XV and XVIII show different expression and localisation in cutaneous squamous cell carcinoma: type XV appears in tumor stroma, while XVIII becomes upregulated in tumor cells and lost from microvessels.Rethinking glomerular basement membrane thickening in diabetic nephropathy: adaptive or pathogenic?Antisense MMP-9 RNA inhibits malignant glioma cell growth in vitro and in vivo.Enhancement of recombinant human endostatin on the radiosensitivity of human pulmonary adenocarcinoma A549 cells and its mechanism.Recombinant human collagen XV regulates cell adhesion and migrationCharacterization of the anti-angiogenic properties of arresten, an alpha1beta1 integrin-dependent collagen-derived tumor suppressorEndostatin therapy reveals a U-shaped curve for antitumor activity.Peptide inhibition of catalytic and noncatalytic activities of matrix metalloproteinase-9 blocks tumor cell migration and invasion.Evaluation of recombinant endostatin in the treatment of atherosclerotic plaques and neovascularization in rabbits.Activation of protein tyrosine kinases and matrix metalloproteinases causes blood-brain barrier injury: Novel mechanism for neurodegeneration associated with alcohol abuseIntraperitoneal gene therapy by rAAV provides long-term survival against epithelial ovarian cancer independently of survivin pathway.Endostatin expression in the murine model of ischaemia/reperfusion-induced acute renal failure.Overexpression of angiomotin in sinonasal inverted papilloma.Serum Endostatin Levels in Oral Squamous Cell Carcinoma.Fluctuating roles of matrix metalloproteinase-9 in oral squamous cell carcinoma
P2860
Q22000109-BEA330A6-A055-4E75-A1B2-0827A23414F7Q24568374-9E5E1B09-1092-4A80-A4CD-A60403D24C99Q33592796-15ABA6BE-12BB-4704-AF80-8E70BD4508F3Q33615103-4A13431A-6786-428F-BB5E-A3269C71E891Q34008657-2754E690-596D-4CAE-9779-237FACE4A8C7Q34148203-E919FADF-558E-42C9-B4A3-5EFAFEC52FFBQ34354606-67A44C5E-CEFD-4A16-BF47-54ED88C0A824Q34387893-058E148E-0B24-49A4-AB4F-55D716943535Q35902328-297A5732-377B-407B-8B49-6E093182C570Q36066150-311B3F3F-2A06-4AE5-AD9B-DABD9762D30AQ36220259-FDF52A3B-CED8-42EB-8731-4BB26B75007CQ36578668-EA9BBEF4-075A-4B44-99FA-3687E4A69CBCQ36600610-971CF67B-6B0F-4B25-AE92-5B88D5BF45F1Q36672855-106E04F7-668A-4135-9B01-DBDCE2E4154EQ36742135-2552BFF9-071D-45CF-B979-0BA2C28B3560Q37100147-FCD58CEB-C74B-4ADF-A252-01B7671F9CECQ37129834-AF3606A2-027E-4B81-8DB9-7F0992EB3EC5Q37316568-2BA936FC-BD89-4711-AF92-A0E6DA77C1D1Q37334058-40DB6ADB-9221-4BC5-811D-000B3EFD45BCQ37346912-211544F9-0C48-4F82-9C88-A57427ACF5A8Q37567780-0153902F-72D8-4DE0-A7C6-C5FB58A26957Q37636855-44489CFB-25AC-4B4E-8D7A-10BF75CFC9C9Q38210749-5AE530AD-95D4-4521-867E-9A0F7F41C23FQ38644204-EB69F6D3-7384-4A24-BF13-E14261EBC404Q38739605-D83DA99E-FFDC-4D4D-86A3-F426024F1C62Q38812206-402BB88C-C205-46C0-B5D7-92657BD9D68EQ38942962-3E59844A-599A-4C69-AD51-27792215EC52Q39212676-2949EEB9-5E34-41B6-A9ED-4DA08BDF6E9CQ39317159-FE904C6B-FB7F-49AF-A66B-595EEC1185D7Q39757914-71E72226-69CD-4E5C-8E05-D7FB3EF851FDQ39942587-A8356F0E-397F-419B-8CBF-F9E46399AF2FQ40321040-6A8FCCC2-3510-4549-84C1-02E71A3B7AFDQ40559840-4A8376A5-66EF-474A-A6FC-B4CC2849D1B0Q42018678-73D2C1F3-41C0-4C46-AC35-70C7A090D273Q42229231-FA58D829-2DCE-49DF-9ADA-4B43A354F683Q45862137-5A0CFCBF-D38B-49D5-8D36-AC18E2D01857Q53530123-F3B6486C-C25F-4F49-AD09-321D93B5D599Q54222466-9EE4C415-2EC7-4CE3-9B16-7AACA6449BF3Q55040630-28417C15-978E-470A-BD06-5B113502E9D7Q59034785-F45DB2E3-4721-4FFA-8702-37EAFAF24699
P2860
Endostatin inhibits human tongue carcinoma cell invasion and intravasation and blocks the activation of matrix metalloprotease-2, -9, and -13.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Endostatin inhibits human tong ...... etalloprotease-2, -9, and -13.
@en
type
label
Endostatin inhibits human tong ...... etalloprotease-2, -9, and -13.
@en
prefLabel
Endostatin inhibits human tong ...... etalloprotease-2, -9, and -13.
@en
P2093
P2860
P356
P1476
Endostatin inhibits human tong ...... etalloprotease-2, -9, and -13.
@en
P2093
Jani Luostarinen
Pia Heikkilä
Pia Nyberg
Ritva Heljasvaara
Taina Pihlajaniemi
Timo Sorsa
Tuula Salo
P2860
P304
22404-22411
P356
10.1074/JBC.M210325200
P407
P577
2003-04-10T00:00:00Z